Alchemical Free Energy Methods Applied to Complexes of the First Bromodomain of BRD4

被引:12
|
作者
Guest, Ellen E. [1 ]
Cervantes, Luis F. [2 ]
Pickett, Stephen D. [3 ]
Brooks, Charles L., III [2 ]
Hirst, Jonathan D. [1 ]
机构
[1] Univ Nottingham, Sch Chem, Univ Pk, Nottingham NG7 2RD, England
[2] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA
[3] GlaxoSmithKline RD Pharmaceut, Computat Chem, Stevenage SG1 2NY, Herts, England
基金
英国工程与自然科学研究理事会; 美国国家卫生研究院;
关键词
MOLECULAR-DYNAMICS; LAMBDA-DYNAMICS; CHARMM; SIMULATION; PREDICTION; CONSTRAINTS; INTEGRATION; PRECISE; SPACE;
D O I
10.1021/acs.jcim.1c01229
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Accurate and rapid predictions of the binding affinity of a compound to atarget are one of the ultimate goals of computer aided drug design. Alchemicalapproaches to free energy estimations follow the path from an initial state of the systemto thefinal state through alchemical changes of the energy function during a moleculardynamics simulation. Herein, we explore the accuracy and efficiency of two suchtechniques: relative free energy perturbation (FEP) and multisite lambda dynamics(MS lambda D). These are applied to a series of inhibitors for the bromodomain-containingprotein 4 (BRD4). We demonstrate a procedure for obtaining accurate relative bindingfree energies using MS lambda D when dealing with a change in the net charge of the ligand.This resulted in an impressive comparison with experiment, with an average difference of0.4 +/- 0.4 kcal mol-1. In a benchmarking study for the relative FEP calculations, we foundthat using 20 lambda windows with 0.5 ns of equilibration and 1 ns of data collection foreach window gave the optimal compromise between accuracy and speed. Overall, relativeFEP and MS lambda D predicted binding free energies with comparable accuracy, an average of0.6 kcal mol-1for each method. However, MS lambda D makes predictions for a larger molecular space over a much shorter time scale thanrelative FEP, with MS lambda D requiring a factor of 18 times less simulation time for the entire molecule space
引用
收藏
页码:1458 / 1470
页数:13
相关论文
共 50 条
  • [31] Structural basis and binding properties of the second bromodomain of Brd4 with acetylated histone tails
    Liu, Ying
    Wang, Xiqing
    Zhang, Jiahai
    Huang, Hongda
    Ding, Bo
    Wu, Jihui
    Shi, Yunyu
    BIOCHEMISTRY, 2008, 47 (24) : 6403 - 6417
  • [32] Epigenetic targeting of bromodomain protein BRD4 counteracts cancer cachexia and prolongs survival
    Marco Segatto
    Raffaella Fittipaldi
    Fabrizio Pin
    Roberta Sartori
    Kyung Dae Ko
    Hossein Zare
    Claudio Fenizia
    Gianpietro Zanchettin
    Elisa Sefora Pierobon
    Shinji Hatakeyama
    Cosimo Sperti
    Stefano Merigliano
    Marco Sandri
    Panagis Filippakopoulos
    Paola Costelli
    Vittorio Sartorelli
    Giuseppina Caretti
    Nature Communications, 8
  • [33] The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expression
    Yu Xiong
    Linli Li
    Liting Zhang
    Yangyang Cui
    Chengyong Wu
    Hui Li
    Kai Chen
    Qiuyuan Yang
    Rong Xiang
    Yiguo Hu
    Shile Huang
    Yuquan Wei
    Shengyong Yang
    Cell Death & Differentiation, 2019, 26 : 1929 - 1941
  • [34] The bromodomain protein BRD4 positively regulates necroptosis via modulating MLKL expression
    Xiong, Yu
    Li, Linli
    Zhang, Liting
    Cui, Yangyang
    Wu, Chengyong
    Li, Hui
    Chen, Kai
    Yang, Qiuyuan
    Xiang, Rong
    Hu, Yiguo
    Huang, Shile
    Wei, Yuquan
    Yang, Shengyong
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (10): : 1929 - 1941
  • [35] The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis
    Dey, A
    Chitsaz, F
    Abbasi, A
    Misteli, T
    Ozato, K
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (15) : 8758 - 8763
  • [36] FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression
    Yang, Chong
    Zhu, Shikai
    Yang, Hongji
    Fan, Ping
    Meng, Zibo
    Zhao, Jingyuan
    Zhang, Kun
    Jin, Xin
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (02): : 523 - +
  • [37] Segmental Isotope Labelling of an Individual Bromodomain of a Tandem Domain BRD4 Using Sortase A
    Williams, Felix P.
    Milbradt, Alexander G.
    Embrey, Kevin J.
    Bobby, Romel
    PLOS ONE, 2016, 11 (04):
  • [38] Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein brd4
    Yang, ZY
    Yik, JHN
    Chen, RC
    He, NH
    Jang, MK
    Ozato, K
    Zhou, Q
    MOLECULAR CELL, 2005, 19 (04) : 535 - 545
  • [39] Design and synthesis of a dual kinase-bromodomain inhibitor targeting ALK and BRD4
    Watts, Ellen
    Heidenreich, David
    Tucker, Elizabeth
    Bellenie, Benjamin
    Knapp, Stefan
    Chesler, Louis
    Hoelder, Swen
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [40] Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD
    Zhou, Xia
    Fan, Lucy X.
    Peters, Dorien J. M.
    Trudel, Marie
    Bradner, James E.
    Li, Xiaogang
    HUMAN MOLECULAR GENETICS, 2015, 24 (14) : 3982 - 3993